{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T18:52:17Z","timestamp":1767898337932,"version":"3.49.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.molimm.2025.11.014","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T01:55:12Z","timestamp":1764640512000},"page":"41-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Verticinone inhibits cell growth and induces pyroptosis via regulating AKT pathway in papillary thyroid cancer"],"prefix":"10.1016","volume":"189","author":[{"given":"Xincheng","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2025.11.014_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104270","article-title":"The unconventional role of Akt1 in the advanced cancers and in diabetes-promoted carcinogenesis","volume":"145","author":"Alwhaibi","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.molimm.2025.11.014_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.dib.2019.104828","article-title":"Data on possible in vitro anti-diabetic effects of verticinone on \u03b2-TC6 pancreatic and C2C12 skeletal muscle cells","volume":"28","author":"Boojar","year":"2020","journal-title":"Data Brief."},{"issue":"3","key":"10.1016\/j.molimm.2025.11.014_bib3","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA a cancer journal clinicians"},{"issue":"1","key":"10.1016\/j.molimm.2025.11.014_bib4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ecl.2018.10.006","article-title":"Management of Papillary Thyroid Microcarcinoma","volume":"48","author":"Brito","year":"2019","journal-title":"Endocrinol. Metab. Clin. North Am."},{"issue":"6","key":"10.1016\/j.molimm.2025.11.014_bib5","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/jso.21804","article-title":"Thyroid cancer and lymph node metastases","volume":"103","author":"Clark","year":"2011","journal-title":"J. Surg. Oncol."},{"issue":"7","key":"10.1016\/j.molimm.2025.11.014_bib6","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1007\/s12325-020-01391-1","article-title":"Papillary Thyroid Cancer-Aggressive Variants and Impact on Management: A Narrative Review","volume":"37","author":"Coca-Pelaz","year":"2020","journal-title":"Adv. Ther."},{"issue":"11","key":"10.1016\/j.molimm.2025.11.014_bib7","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1530\/EC-20-0311","article-title":"Akt1 genetic variants confer increased susceptibility to thyroid cancer","volume":"9","author":"Crezee","year":"2020","journal-title":"Endocr. Connect."},{"issue":"8","key":"10.1016\/j.molimm.2025.11.014_bib8","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1158\/1541-7786.MCR-20-1066","article-title":"Emerging Roles for AKT Isoform Preference in Cancer Progression Pathways","volume":"19","author":"Degan","year":"2021","journal-title":"Molecular cancer research MCR"},{"issue":"5300","key":"10.1016\/j.molimm.2025.11.014_bib9","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1126\/science.275.5300.661","article-title":"Regulation of neuronal survival by the serine-threonine protein kinase Akt","volume":"275","author":"Dudek","year":"1997","journal-title":"Science (New York N. Y. )"},{"issue":"6","key":"10.1016\/j.molimm.2025.11.014_bib10","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/s41416-024-02778-5","article-title":"The AKT inhibitor AZD5363 elicits synthetic lethality in ARID1A-deficient gastric cancer cells via induction of pyroptosis","volume":"131","author":"Fang","year":"2024","journal-title":"Br. J. Cancer"},{"issue":"12","key":"10.1016\/j.molimm.2025.11.014_bib11","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/annonc\/mdz400","article-title":"Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2020","volume":"30","author":"Filetti","year":"2019","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"issue":"2","key":"10.1016\/j.molimm.2025.11.014_bib12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ctrv.2003.07.007","article-title":"PI3K\/Akt signalling pathway and cancer","volume":"30","author":"Fresno Vara","year":"2004","journal-title":"Cancer Treat. Rev."},{"issue":"15","key":"10.1016\/j.molimm.2025.11.014_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/cells11152290","article-title":"AKT1 Transcriptomic Landscape in Breast Cancer Cells","volume":"11","author":"George","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.molimm.2025.11.014_bib14","unstructured":"Guang-ming, H.J.P.T., Study on the Anagelsic Effect and the Physical Dependence of Verticinone. 2008."},{"issue":"2","key":"10.1016\/j.molimm.2025.11.014_bib15","doi-asserted-by":"crossref","first-page":"024","DOI":"10.1038\/s41419-024-06511-1","article-title":"Ruxolitinib induces apoptosis and pyroptosis of anaplastic thyroid cancer via the transcriptional inhibition of DRP1-mediated mitochondrial fission","volume":"15","author":"Guo","year":"2024","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.molimm.2025.11.014_bib16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41419-020-2476-2","article-title":"Chemotherapy-induced pyroptosis is mediated by BAK\/BAX-caspase-3-GSDME pathway and inhibited by 2-bromopalmitate","volume":"11","author":"Hu","year":"2020","journal-title":"Cell Death Dis."},{"issue":"154528","key":"10.1016\/j.molimm.2025.11.014_bib17","first-page":"27","article-title":"Alantolactone induces concurrent apoptosis and GSDME-dependent pyroptosis of anaplastic thyroid cancer through ROS mitochondria-dependent caspase pathway","volume":"108","author":"Hu","year":"2023","journal-title":"Phytomedicine"},{"issue":"9","key":"10.1016\/j.molimm.2025.11.014_bib18","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.tcb.2017.05.005","article-title":"Gasdermins: Effectors of Pyroptosis","volume":"27","author":"Kovacs","year":"2017","journal-title":"Trends Cell Biol."},{"issue":"6","key":"10.1016\/j.molimm.2025.11.014_bib19","doi-asserted-by":"crossref","DOI":"10.3892\/etm.2024.12737","article-title":"Peimine induces apoptosis of glioblastoma cells through regulation of the PI3K\/AKT signaling pathway","volume":"28","author":"Lei","year":"2024","journal-title":"Exp. Ther. Med"},{"issue":"8","key":"10.1016\/j.molimm.2025.11.014_bib20","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1038\/s41418-021-00755-6","article-title":"GSDME-mediated pyroptosis promotes inflammation and fibrosis in obstructive nephropathy","volume":"28","author":"Li","year":"2021","journal-title":"Cell death Differ."},{"issue":"13","key":"10.1016\/j.molimm.2025.11.014_bib21","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.steroids.2012.08.013","article-title":"A novel chenodeoxycholic acid-verticinone ester induces apoptosis and cell cycle arrest in HepG2 cells","volume":"77","author":"Liang","year":"2012","journal-title":"Steroids"},{"issue":"8","key":"10.1016\/j.molimm.2025.11.014_bib22","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41419-024-06985-z","article-title":"Prosapogenin A induces GSDME-dependent pyroptosis of anaplastic thyroid cancer through vacuolar ATPase activation-mediated lysosomal over-acidification","volume":"15","author":"Liu","year":"2024","journal-title":"Cell Death Dis."},{"issue":"31","key":"10.1016\/j.molimm.2025.11.014_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf3657","article-title":"Characterizing dedifferentiation of thyroid cancer by integrated analysis","volume":"7","author":"Luo","year":"2021","journal-title":"Sci. Adv."},{"issue":"5","key":"10.1016\/j.molimm.2025.11.014_bib24","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1089\/thy.2021.0662","article-title":"Thyroid Cancer Incidence and Mortality Trends in the United States: 2000-2018","volume":"32","author":"Megwalu","year":"2022","journal-title":"Thyroid. Off. J. Am. Thyroid. Assoc."},{"key":"10.1016\/j.molimm.2025.11.014_bib25","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.semcancer.2020.01.005","article-title":"Molecular therapeutics for anaplastic thyroid cancer","volume":"61","author":"Pozdeyev","year":"2020","journal-title":"Semin. Cancer Biol."},{"issue":"9","key":"10.1016\/j.molimm.2025.11.014_bib26","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.7150\/thno.71086","article-title":"Pyroptosis in inflammatory diseases and cancer","volume":"12","author":"Rao","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.molimm.2025.11.014_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14128","article-title":"Cleavage of DFNA5 by caspase-3 during apoptosis mediates progression to secondary necrotic\/pyroptotic cell death","volume":"8","author":"Rogers","year":"2017","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.molimm.2025.11.014_bib28","doi-asserted-by":"crossref","first-page":"021","DOI":"10.1038\/s41420-020-00398-5","article-title":"Caspase 3\/GSDME-dependent pyroptosis contributes to chemotherapy drug-induced nephrotoxicity","volume":"12","author":"Shen","year":"2021","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.molimm.2025.11.014_bib29","first-page":"7","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA a cancer journal clinicians"},{"issue":"1","key":"10.1016\/j.molimm.2025.11.014_bib30","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3390\/cancers6010526","article-title":"The Role of STAT3 in Thyroid Cancer","volume":"6","author":"Sosonkina","year":"2014","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.molimm.2025.11.014_bib31","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0002-9440(10)61714-2","article-title":"AKT1\/PKBalpha kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells","volume":"159","author":"Sun","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.molimm.2025.11.014_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcp.2022.101863","article-title":"miR-451a suppresses papillary thyroid cancer cell proliferation and invasion and facilitates apoptosis through targeting DCBLD2 and AKT1","volume":"66","author":"Tan","year":"2022","journal-title":"Mol. Cell. probes"},{"issue":"114108","key":"10.1016\/j.molimm.2025.11.014_bib33","first-page":"8","article-title":"Peimine inhibits cell proliferation and migration of breast cancer via regulating the O-GlcNAcylation of USP41","volume":"149","author":"Wang","year":"2025","journal-title":"Int Immunopharmacol."},{"issue":"7661","key":"10.1016\/j.molimm.2025.11.014_bib34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature22393","article-title":"Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin","volume":"547","author":"Wang","year":"2017","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.molimm.2025.11.014_bib35","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/s41423-022-00905-x","article-title":"Role of pyroptosis in inflammation and cancer","volume":"19","author":"Wei","year":"2022","journal-title":"Cell. Mol. Immunol."},{"issue":"10","key":"10.1016\/j.molimm.2025.11.014_bib36","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1055\/s-0035-1546170","article-title":"Imperialine and Verticinone from Bulbs of Fritillaria wabuensis Inhibit Pro-inflammatory Mediators in LPS-stimulated RAW 264.7 Macrophages","volume":"81","author":"Wu","year":"2015","journal-title":"Planta Med."},{"issue":"12","key":"10.1016\/j.molimm.2025.11.014_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15123221","article-title":"Nigericin Boosts Anti-Tumor Immune Response via Inducing Pyroptosis in Triple-Negative Breast Cancer","volume":"15","author":"Wu","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.molimm.2025.11.014_bib38","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/s12964-023-01359-y","article-title":"Simvastatin induces pyroptosis via ROS\/caspase-1\/GSDMD pathway in colon cancer","volume":"21","author":"Xie","year":"2023","journal-title":"Cell communication signaling CCS"},{"issue":"9871","key":"10.1016\/j.molimm.2025.11.014_bib39","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0140-6736(13)60109-9","article-title":"Progress in molecular-based management of differentiated thyroid cancer","volume":"381","author":"Xing","year":"2013","journal-title":"Lancet (Lond. Engl. )"},{"issue":"1","key":"10.1016\/j.molimm.2025.11.014_bib40","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41392-021-00507-5","article-title":"Pyroptosis: mechanisms and diseases","volume":"6","author":"Yu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"3","key":"10.1016\/j.molimm.2025.11.014_bib41","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/ptr.2345","article-title":"Verticinone induces cell cycle arrest and apoptosis in immortalized and malignant human oral keratinocytes","volume":"22","author":"Yun","year":"2008","journal-title":"Phytother. Res. PTR"},{"issue":"4-5","key":"10.1016\/j.molimm.2025.11.014_bib42","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.steroids.2008.12.007","article-title":"Structural analysis and antitussive evaluation of five novel esters of verticinone and bile acids","volume":"74","author":"Zhang","year":"2009","journal-title":"Steroids"},{"issue":"5","key":"10.1016\/j.molimm.2025.11.014_bib43","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/aps.2009.43","article-title":"Addictive evaluation of cholic acid-verticinone ester, a potential cough therapeutic agent with agonist action of opioid receptor","volume":"30","author":"Zhang","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"issue":"8","key":"10.1016\/j.molimm.2025.11.014_bib44","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.apsb.2020.06.015","article-title":"Miltirone induces cell death in hepatocellular carcinoma cell through GSDME-dependent pyroptosis","volume":"10","author":"Zhang","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"issue":"7-8","key":"10.1016\/j.molimm.2025.11.014_bib45","first-page":"631","article-title":"Preparation and antitussive, expectorant, and antiasthmatic activities of verticinone's derivatives","volume":"10","author":"Zhang","year":"2008","journal-title":"J. Asian Nat. Prod. Res."},{"issue":"7799","key":"10.1016\/j.molimm.2025.11.014_bib46","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41586-020-2071-9","article-title":"Gasdermin E suppresses tumour growth by activating anti-tumour immunity","volume":"579","author":"Zhang","year":"2020","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.molimm.2025.11.014_bib47","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1159\/000495646","article-title":"Peiminine Inhibits Glioblastoma in Vitro and in Vivo Through Cell Cycle Arrest and Autophagic Flux Blocking","volume":"51","author":"Zhao","year":"2018","journal-title":"Cell Physiol. Biochem"},{"issue":"10","key":"10.1016\/j.molimm.2025.11.014_bib48","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1080\/15384101.2020.1743911","article-title":"Metformin activates AMPK\/SIRT1\/NF-\u03baB pathway and induces mitochondrial dysfunction to drive caspase3\/GSDME-mediated cancer cell pyroptosis","volume":"19","author":"Zheng","year":"2020","journal-title":"Cell cycle (Georgetown Tex. )"},{"issue":"6494","key":"10.1016\/j.molimm.2025.11.014_bib49","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaz7548","article-title":"Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells","volume":"368","author":"Zhou","year":"2020","journal-title":"Science (New York N. Y. )"},{"key":"10.1016\/j.molimm.2025.11.014_bib50","unstructured":"Zhou Qing, Z.J.W.Y., 2015. Inhibitory Effect of Chenodeoxycholic Acid-verticinone Ester on Tumor Growth of H22- bearing Mice. HERALD OF MEDICINE 2015, 34, (4), 467-470.."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016158902500269X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016158902500269X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T14:06:26Z","timestamp":1767881186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016158902500269X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":50,"alternative-id":["S016158902500269X"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2025.11.014","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Verticinone inhibits cell growth and induces pyroptosis via regulating AKT pathway in papillary thyroid cancer","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2025.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}